Illustrative image – not actual.
Minister for Information Technology, Industries & Commerce, Municipal Administration and Urban Development, government of Telangana, K T Rama Rao, inaugurated a new plant of Biological E (BE) and unveiled Typhoid Conjugate Vaccine (TCV) in the Special Economic Zone at Genome Valley in Kolthur village on the outskirts of Hyderabad, Telangana, on 17 February 2020.
The foundation stone for the project was laid during BioAsia 2017, and got inaugurated during 17th edition of BioAsia.
The company has made an investment to the tune of Rs 300 crore for building the plant, which is now ready for commercial production. The project is spread over 29 acre of land parcel.
The plant will create employment opportunities for around 1,000 people. The new facility will help the existing vaccines plant enhance production and manufacture new products which are in the pipeline.
TCV is an injectable single-dose vaccine to be administered to children from six months old as well as adults. It contains Vi Polysaccharide derived from C Freundii conjugated to CRM197 protein. The vaccine has been developed in partnership with the GSK Vaccines Institute for Global Health, based in Siena (Italy), which first developed the asset and transferred it to BE in 2013.
The vaccine will be manufactured in the company’s GMP manufacturing facilities in Hyderabad and can be commercially available within three months.
